StockData
Surrozen, Inc./DE logo

Surrozen, Inc./DE (SRZN) stock

SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$29.98−2.34 (-7.24%)

Close on Nov 17, 2026Market cap $352.37MP/E –Yield –

Surrozen price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Surrozen's price to sales ratio was 32.6× on Nov 11, 2026, against 39.4× a year earlier.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Nov 11, 202632.6×−21.2
2025Dec 31, 202553.7×–

More Surrozen figures

See a number that looks wrong?